{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:07Z","timestamp":1786119607898,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1097\/mbc.0b013e32833e47c1","type":"journal-article","created":{"date-parts":[[2010,8,25]],"date-time":"2010-08-25T03:23:28Z","timestamp":1282706608000},"page":"674-678","source":"Crossref","is-referenced-by-count":7,"title":["Platelet glycoprotein IIIa (platelet antigen 1\/platelet antigen 2) polymorphism and 1-year outcome in patients with stable coronary artery disease"],"prefix":"10.1097","volume":"21","author":[{"given":"Faouzi","family":"Addad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Elalamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahar","family":"Chakroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Abderrazek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohra","family":"Dridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Hamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohssen","family":"Hassine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Ben-Farhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigoris","family":"Gerotziafas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Hatmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habib","family":"Gamra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210203","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Davi","year":"2007","journal-title":"N Engl J Med"},{"key":"R2-10-20210203","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1056\/NEJM199506083322306","article-title":"Platelet glycoprotein IIb\/IIIa receptors in cardiovascular medecine","volume":"332","author":"Lefkovits","year":"1995","journal-title":"N Engl J Med"},{"key":"R3-10-20210203","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1182\/blood.V80.6.1386.1386","article-title":"The molecular immunology of human platelet proteins","volume":"80","author":"Kunicki","year":"1992","journal-title":"Blood"},{"key":"R4-10-20210203","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1172\/JCI114082","article-title":"The humain platelet alloantigen, PlA1 and PlA2 are associated with leucine 33 to praline aminoacid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing","volume":"83","author":"Newman","year":"1989","journal-title":"J Clin Invest"},{"key":"R5-10-20210203","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJM199604253341703","article-title":"A polymorphism of platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis","volume":"334","author":"Weiss","year":"1996","journal-title":"N Engl J Med"},{"key":"R6-10-20210203","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(97)80010-4","article-title":"PlA1\/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis","volume":"349","author":"Ridker","year":"1997","journal-title":"Lancet"},{"key":"R7-10-20210203","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1055\/s-0038-1656134","article-title":"The Leu33\/Pro polymorphism (PlA1\/PlA2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM study. Etude Cas-Temoins de l'Infarctus du Myocarde","volume":"77","author":"Herrman","year":"1997","journal-title":"Thromb Haemost"},{"key":"R8-10-20210203","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0735-1097(98)00603-2","article-title":"Association between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease","volume":"33","author":"Anderson","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"R9-10-20210203","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1055\/s-0037-1613863","article-title":"HPA-1 and HPA-3 polymorphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction","volume":"83","author":"Bottiger","year":"2000","journal-title":"Thromb Haemost"},{"key":"R10-10-20210203","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0735-1097(03)00781-2","article-title":"Platelet glycoprotein IIb\/IIIa PlA2\/PlA2 homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in yong men, the Copenhagen City Heart Study","volume":"42","author":"Bojesen","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R11-10-20210203","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/S0735-1097(01)01702-8","article-title":"American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes: a report of the American College of Cardiology task force on clinical data standards (acute coronary syndromes writing committee)","volume":"38","author":"Cannon","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R12-10-20210203","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1034\/j.1399-0039.1999.540214.x","article-title":"Gene frequencies of human platelet antigens in the Tunisian population","volume":"54","author":"Mojaat","year":"1999","journal-title":"Tissus Antigens"},{"key":"R13-10-20210203","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0002-9149(98)00235-5","article-title":"PlA1\/A2 polymorphism of glycoprotein IIIa and risk of coronary artery disease and restenosis following coronary angioplasty","volume":"82","author":"Mamotte","year":"1998","journal-title":"Am J Cardiol"},{"key":"R14-10-20210203","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0735-1097(00)00709-9","article-title":"PlA polymorphism of glycoprotein IIIa and risk for adverse events after coronary stent placement","volume":"36","author":"Kastrati","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R15-10-20210203","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0002-9149(01)01677-0","article-title":"The platelet PlA2 and angiotensin-converting enzyme (ACE) D allele polymorphisms and risk of recurrent events after acute myocardial infarction","volume":"88","author":"Bray","year":"2001","journal-title":"Am J Cardiol"},{"key":"R16-10-20210203","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1477-9560-5-19","article-title":"Effect of PlA1\/PlA2 glycoprotein IIIa gene polymorphism on the long-term outcome after successful coronary stenting","volume":"5","author":"Le Hello","year":"2007","journal-title":"Thromb J"},{"key":"R17-10-20210203","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1055\/s-0037-1615644","article-title":"Platelet glycoprotein receptor IIIa polymorphism PlA1\/PlA2 and coronary risk: a meta-analysis","volume":"85","author":"Di Castenuovo","year":"2001","journal-title":"Thromb Haemost"},{"key":"R18-10-20210203","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/sim.1375","article-title":"A meta-analysis of studies on the association of platelet PLA polymorphism of glycoprotein IIIa and risk of coronary heart study","volume":"22","author":"Burr","year":"2003","journal-title":"Stat Med"},{"key":"R19-10-20210203","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1161\/01.ATV.19.4.1142","article-title":"Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism: the Framingham Offspring Study","volume":"19","author":"Feng","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R20-10-20210203","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1161\/01.CIR.101.9.1013","article-title":"Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists","volume":"101","author":"Michelson","year":"2000","journal-title":"Circulation"},{"key":"R21-10-20210203","first-page":"1350","article-title":"The effect of glycoprotein IIIa A1\/A2 gene polymorphism on one-year outcome in patients with ST-segment elevation myocardial infraction treated with primary percutaneous coronary intervention","volume":"64","author":"Kozieradzka","year":"2006","journal-title":"Kardiol Pol"},{"key":"R22-10-20210203","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0167-5273(02)00412-6","article-title":"Association between the PlA platelet glycoprotein GPIIIa polymorphism and extent of coronary artery disease","volume":"88","author":"Grucha\u0142a","year":"2003","journal-title":"Int J Cardiol"},{"key":"R23-10-20210203","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0021-9150(00)00683-3","article-title":"The GPIIIa (\u03b23 integrin) PlA polymorphism in the early development of coronary atherosclerosis","volume":"154","author":"Michelsson","year":"2001","journal-title":"Atherosclerosis"},{"key":"R24-10-20210203","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1046\/j.1365-2141.2000.02300.x","article-title":"defective platelet response to arachidonic acid and thromboxane A2 in subjects with PlA2 polymorphism of \u03b23 subunit (glycoprotein IIIa)","volume":"110","author":"Andrioli","year":"2000","journal-title":"Br J Haematol"},{"key":"R25-10-20210203","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1365-2141.1997.4973300.x","article-title":"Interdonor variability of platelet response to thrombin receptor activation: influence of PlA2 polymorphism","volume":"99","author":"Lasne","year":"1997","journal-title":"Br J Haematol"},{"key":"R26-10-20210203","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0735-1097(03)00921-5","article-title":"Resistance in vitro to low-dose aspirin is associated with platelet Pl (GP IIIa) polymorphism but not with C807T (GP Ia\/I1a) and C-5T Kozak (GP Ib\u03b1) polymorphism","volume":"42","author":"Macchi","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R27-10-20210203","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.amjcard.2004.03.005","article-title":"Effect of glycoprotein IIIa PlA2 polymorphism on outcome of patients with stable coronary artery disease and effect of smoking","volume":"93","author":"Lopes","year":"2004","journal-title":"Am J Cardiol"},{"key":"R28-10-20210203","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0009-9120(98)00077-0","article-title":"Platelt glycoprotein IIb\/IIIa genetic polymorphism is associated with plasma fibrinogen levels in myocardial infarction patients","volume":"31","author":"Senti","year":"1998","journal-title":"Clin Biochem"},{"key":"R29-10-20210203","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1742-1241.2007.01344.x","article-title":"The genetics of aspirin resistance","volume":"61","author":"Goodman","year":"2007","journal-title":"Int J Clin Pract"},{"key":"R30-10-20210203","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1067\/mhj.2002.119763","article-title":"Reduced inhibition by abciximab in platelets with the PlA2 polymorphism","volume":"143","author":"Wheeler","year":"2002","journal-title":"Am Heart J"},{"key":"R31-10-20210203","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00001721-200401000-00014","article-title":"PlA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation","volume":"15","author":"Angiolillo","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R32-10-20210203","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/17482940902785474","article-title":"Role of PlA2 polymorphism on clinical events after percutaneous coronary intervention","volume":"11","author":"Syros","year":"2009","journal-title":"Acute Card Care"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001721-201010000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:42:05Z","timestamp":1786041725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-201010000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e32833e47c1","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}